| Company/Division name | Eli Lilly and Company |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 460 |
| Year reshoring announced: | 2021 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 33.16 |
| City reshored to: | Durham |
| State(s) reshored to: | NC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Diabetes drugs, pharmaceuticals |
| What domestic positive factors made reshoring more attractive? | Infrastructure, Other, import replacement |
